Get 'huge and juicy' tomato plants with one food scrap gardeners say is best
Tomatoes are notorious for their hefty appetite for nutrients to produce bountiful crops, but alas, even the richest potting compost isn't quite up to snuff for these hungry plants.
Without a proper feast of nutrients, tomato plants soon show signs of hunger, with the underwhelming fruit giving the game away. They're desperate for fertilisers chock-full of nitrogen, phosphorus, and potassium to thrive.
For those with green fingers looking to save a penny or two, concocting a homemade fertiliser can be a wallet-friendly alternative to pricey shop-bought organic options, without skimping on the bloom. In other related news, Brits are told to never put one banned item in garden bins as you could face punishment.
In search of organic solutions for her tomato troubles, one woman reached out to the Gardening UK Facebook group in pursuit of some sage advice, reports the Express. Emma Wood asked the group: "I've been using this tomato feed from Sainsbury's for a while, but it's run out now. Is there an organic alternative I can use instead?".
Banana peels quickly emerged as a stellar recommendation, brimming with potassium, perfect for plumping up tomatoes. Jane Wilson advised: "Banana peels contain potassium, which helps tomatoes to grow more huge and juicy fruit. To use it on your plant either add it to compost first or cut it up and bury it around the plant."
Echoing this sentiment, Lisa Marsden confirmed: "Banana peels will fertilise the plant and prevent any diseases from developing." Rosalyn Fair chimed in with her own experience: "When I don't have any of my Tomorite left I often use banana peels. I heard that it's the best as it helps tomato plants to produce bigger fruit."
Green-fingered Glenn Fields chimed in: "Even though banana peels don't contain nitrogen, I still feel like it does the best job when fertilising the plant. I used them last year and my tomatoes had never grown so big. I'm hoping for the same outcome this year."
Meanwhile, Sara Dunster shared her method: "I like to add a single banana peel to each planting hole before planting the tomatoes. Then in summer I just add one to two peels around the top of the plant's soil around the plant."
Banana skins have emerged as the go-to trick for clever gardeners, bursting with potassium levels that help tomato plants transport nutrients and water between cells. This doesn't just boost your harvest but delivers fruit with incredible flavour too.
Many gardening fans swear by these kitchen scraps as top-notch fertiliser, especially because they're nitrogen-free. Whilst nitrogen supports plant development, too much creates leafy growth at the expense of fruit production.
To boost your tomatoes with a potassium hit using banana peels, simply dig them in close by for a gradual release of nutrients. Best practice is introducing this natural treat at planting time, then adding another helping once fruit formation begins.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
19 minutes ago
- Scottish Sun
‘Remarkable' new vaccine shown to slow down world's deadliest cancer in move to ‘beat cancer for everyone'
Cancer patients survived around two years and five months after receiving the new jab FRESH HOPE 'Remarkable' new vaccine shown to slow down world's deadliest cancer in move to 'beat cancer for everyone' Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) THOUSANDS of Brits with cancer have been given fresh hope as a new jab could slow down the disease and boost survival. The vaccine, described as "remarkable" by scientists, has shown promising results in the fight against one of the deadliest forms of the disease - pancreatic cancer. Sign up for Scottish Sun newsletter Sign up 1 The new jab trains the immune system to attack mutated genes found in many pancreatic and bowel cancers Credit: Getty - Contributor Early trials have proven the jab's ability to supercharge the immune system, enabling it to attack cancer cells and potentially prolong life for patients. More trials are now underway among a larger group of pancreatic and bowel cancer patients, as experts warn it is "too early" to say whether the jab will work at scale. Pancreatic cancer, which affects around 10,000 Brits each year, is the deadliest cancer in the world. And only about seven out of 100 of them will survive it for five years or more, according to Cancer Research UK. This is partly because it shows no symptoms until it has already spread to other parts of the body, making it incredibly hard to treat. While surgery, chemotherapy and radiation can help extend life, they rarely offer a cure. But researchers are now optimistic that this new vaccine could change that, providing a vital new treatment option other therapies fall short. 'Our results show that in the group of patients who had profound immune responses 68 per cent) we saw longer survival than we have expected in this cancer,' said Dr Zev Wainberg, study lead from the University of California, Los Angeles. 'Quite a remarkable finding to occur in a phase 1 trial.' The jab targets a mutated gene called KRAS, which is found in many pancreatic and bowel cancers. I'm a doctor, NEVER ignore these pancreatic cancer symptoms It's a type of immunotherapy vaccine designed to improve the immune system's ability to fight cancer by delivering the vaccine directly to the lymph nodes, which play a crucial role in immune defence. In the phase 1 trial, 20 pancreatic cancer patients and five bowel cancer patients received the vaccine. After 20 months, 68 per cent of patients developed strong immune responses. On average, the pancreatic cancer patients survived around two years and five months after receiving the vaccine, according to the study published in Nature Medicine. 'Patients with the strongest immune responses lived longer and stayed cancer-free for more than 15 months,' Dr Zev added. While some cancer jabs are personalised to each patient, this jab, ELI-002 2P, has a single version which can be given to all patients. This "off-the-shelf" version means that it can be manufactured in bulk and given more rapidly. Dr Chris Macdonald, head of research at Pancreatic Cancer UK, said: 'This study is a big step forward in treating pancreatic cancer. "The 'off-the-shelf' vaccine approach is quicker, cheaper, and could help many more people.' The study has already led to a phase 2 trial with 144 pancreatic and bowel cancer patients, with results expected in the coming months. Dr Dani Edmunds, research information manager at Cancer Research UK, added: "Although we've helped to double cancer survival in the UK in the past 50 years, progress has not been the same for pancreatic cancer which remains hard to treat. "Therefore, it's promising to see that vaccines could help people with pancreatic and bowel cancer live cancer-free for longer. "The results suggest that the vaccine can boost the immune system against cancer in some people following standard treatment. "These people survived and stayed free from disease for longer than people who didn't get as strong an immune boost following vaccination. "Larger controlled trials are needed to confirm these initial findings about the benefits of the vaccine. "More research is needed to understand why some people benefit from the vaccine while others don't so that we can make sure we're beating cancer for everyone." Dr Magnus Dillon, an oncologist at The Royal Marsden NHS Foundation Trust, said: "It's extremely promising to have a vaccine that seems to stimulate T cell activity in KRAS-driven tumours – these are generally 'immune cold', so therapies which stimulate immune responses in this group of patients are much needed. 'Many patients have these KRAS mutations, so an off-the-shelf vaccine could benefit lots of people – it saves the cost and time required to make a personalised vaccine. 'However, it's a bit early to definitively tell whether this will work to prevent cancer relapse in this group of patients who have had all disease removed at surgery - larger studies will be needed. "A bigger challenge is to see if the activated immune system could also work against established tumours, which have many ways to avoid immune attack and prevent immune cells from entering.'
The Sun
20 minutes ago
- The Sun
‘Remarkable' new vaccine shown to slow down world's deadliest cancer in move to ‘beat cancer for everyone'
THOUSANDS of Brits with cancer have been given fresh hope as a new jab could slow down the disease and boost survival. The vaccine, described as "remarkable" by scientists, has shown promising results in the fight against one of the deadliest forms of the disease - pancreatic cancer. Early trials have proven the jab's ability to supercharge the immune system, enabling it to attack cancer cells and potentially prolong life for patients. More trials are now underway among a larger group of pancreatic and bowel cancer patients, as experts warn it is "too early" to say whether the jab will work at scale. Pancreatic cancer, which affects around 10,000 Brits each year, is the deadliest cancer in the world. And only about seven out of 100 of them will survive it for five years or more, according to Cancer Research UK. This is partly because it shows no symptoms until it has already spread to other parts of the body, making it incredibly hard to treat. While surgery, chemotherapy and radiation can help extend life, they rarely offer a cure. But researchers are now optimistic that this new vaccine could change that, providing a vital new treatment option other therapies fall short. 'Our results show that in the group of patients who had profound immune responses 68 per cent) we saw longer survival than we have expected in this cancer,' said Dr Zev Wainberg, study lead from the University of California, Los Angeles. 'Quite a remarkable finding to occur in a phase 1 trial.' The jab targets a mutated gene called KRAS, which is found in many pancreatic and bowel cancers. I'm a doctor, NEVER ignore these pancreatic cancer symptoms It's a type of immunotherapy vaccine designed to improve the immune system's ability to fight cancer by delivering the vaccine directly to the lymph nodes, which play a crucial role in immune defence. In the phase 1 trial, 20 pancreatic cancer patients and five bowel cancer patients received the vaccine. After 20 months, 68 per cent of patients developed strong immune responses. On average, the pancreatic cancer patients survived around two years and five months after receiving the vaccine, according to the study published in Nature Medicine. 'Patients with the strongest immune responses lived longer and stayed cancer-free for more than 15 months,' Dr Zev added. While some cancer jabs are personalised to each patient, this jab, ELI-002 2P, has a single version which can be given to all patients. This "off-the-shelf" version means that it can be manufactured in bulk and given more rapidly. Dr Chris Macdonald, head of research at Pancreatic Cancer UK, said: 'This study is a big step forward in treating pancreatic cancer. "The 'off-the-shelf' vaccine approach is quicker, cheaper, and could help many more people.' The study has already led to a phase 2 trial with 144 pancreatic and bowel cancer patients, with results expected in the coming months. Dr Dani Edmunds, research information manager at Cancer Research UK, added: "Although we've helped to double cancer survival in the UK in the past 50 years, progress has not been the same for pancreatic cancer which remains hard to treat. "Therefore, it's promising to see that vaccines could help people with pancreatic and bowel cancer live cancer-free for longer. "The results suggest that the vaccine can boost the immune system against cancer in some people following standard treatment. "These people survived and stayed free from disease for longer than people who didn't get as strong an immune boost following vaccination. "Larger controlled trials are needed to confirm these initial findings about the benefits of the vaccine. "More research is needed to understand why some people benefit from the vaccine while others don't so that we can make sure we're beating cancer for everyone." Dr Magnus Dillon, an oncologist at The Royal Marsden NHS Foundation Trust, said: "It's extremely promising to have a vaccine that seems to stimulate T cell activity in KRAS-driven tumours – these are generally 'immune cold', so therapies which stimulate immune responses in this group of patients are much needed. 'Many patients have these KRAS mutations, so an off-the-shelf vaccine could benefit lots of people – it saves the cost and time required to make a personalised vaccine. 'However, it's a bit early to definitively tell whether this will work to prevent cancer relapse in this group of patients who have had all disease removed at surgery - larger studies will be needed. "A bigger challenge is to see if the activated immune system could also work against established tumours, which have many ways to avoid immune attack and prevent immune cells from entering.'
Daily Mirror
3 hours ago
- Daily Mirror
Brits heading to the beach warned of poisonous creature hiding under the sand
A first aid expert has warned beachgoers to watch out for weever fish which bury themselves in shallow sand - and are more common during the warmer months As temperatures rocket this week, countless Brits will be flocking to the seaside, but they're being cautioned about a poisonous creature hiding under the sand. Now that temperatures are rising - finally - again during the last weeks of summer, many of us will be tempted to spend a day at the beach to soak up all the sunshine. However, those looking to cool off in the salty seawater should now be careful to avoid a painful injury. A first aid specialist has alerted beach visitors to be vigilant for weever fish, which conceal themselves in shallow sandy areas. They can be spotted along UK beaches and become more prevalent in hot weather. In other similar news, a warning to Brit tourists planning all-inclusive holidays to Spain. Weever fish are sand-coloured and possess inch-long dorsal spines that can pierce anyone who treads on them. These spines can deliver an agonising sting to their unfortunate victim, destroying their seaside excursion. Sarah Jefferies, a first aid trainer at Emergency First Aid at Work Course, explained: "Weever fish are small, but the pain they cause is intense. If you're walking barefoot through shallow water and suddenly feel a sharp sting, it's likely you've stepped on one. The venom can cause swelling, burning sensations, and in some cases, nausea or dizziness." She advises those who are stung to do the following: Wash the affected area in hot water (as hot as can be tolerated) for 15–30 minutes. This neutralises the venom and relieves pain. Rinse with seawater and then remove any visible spines carefully with tweezers or a credit card. Take ibuprofen or paracetamol to manage pain, and ensure your tetanus vaccinations are up to date. However, weever fish aren't the sole hazard beachgoers must be aware of, reports the Manchester Evening News. Coastal visitors are also encouraged to remain alert for jellyfish, jagged shells or rubbish when in the water or strolling across the sand. Rip currents and tides pose an enormous threat when bathing in the sea, particularly on unmonitored beaches. Folks relishing a day out at the beach should also be on high alert for sunstroke and dehydration, particularly when it comes to children and the elderly. But, don't worry - people can still swim in the sea, and will just have to be careful. With temperatures reaching as high as the 31 °C mark, for those who have run out of annual leave days, what better way to enjoy a day off down the coastline and have a nice swim in the ocean?
